Chengcheng Song

Healthcare | Life Sciences, Bioprocessing, IVD

Industrial｜Energy, Building Technology

Healthcare｜Biotech（I&I，Rare Diseases，CV/Metabolic） --Strategic Planning & China Portfolio Strategy: In-depth analysis, valuation evaluation and adjustment of commercialized drugs and future R&D pipeline of Amgen and its partner (BeiGene). --Biologics Investment Analysis: Valuation modeling& clinical trial analysis, due diligence, full participation in disease market sizing, pipeline analysis & clinical expert interviews, I&I, RD, CV. --Clinical Trial Analysis and Arrangement: Participating in the design of China clinical trial for an oncology drug combination therapy and the analysis of expected revenue after launch. --Industry Research Report: Assisted in the completion of a China biotech BD research report, assisted in data analysis, as well as capital structure and corporate strategy research for the case. --Interview Questionnaire Design and Negotiation: Independently completed expert interview questionnaires for 3 types of indications, and participated in 1 preclinical drug BD negotiation.

(Paxlovid, Zavicefta, CRESEMBA, Emblaveo) Healthcare｜Pharmaceutical（Anti-Infectives）, IVD -Launch of New Diagnostics Project: Supported the full lifecycle of diagnostics projects for two innovative drugs, covering from RDT product&technology selection to clinical trials and market deployment; -Strategic Planning: Contributed to mid-year BP & OP strategy sessions for 1 product (Paxlovid) and 2 diagnosis projects (ZAVICEFTA& CREZEMBA）, including data analysis, KPI analysis and patient journey modeling; -Market Campaign Execution: Played a role in planning and executing 3 pharmaceutical marketing campaigns and supported sponsorship for a major academic conference.

Emerging Industry (Defense, Auto, Semiconductor) --Investment target selection: Using strategic analysis and company valuation techniques, assist analysts in identifying high-growth potential investment targets through industry research, policy analysis and company financial analysis; --Independent Reports: Independently completed writing first coverage reports on 2 company, including industry research, equity valuation and other aspects, covering semiconductor, automotive and other industries.